[Proceedings of The National Academy of Sciences of The United States of America] Investigators reported significant transcriptomic signatures of Cas13bt3 expression in retinal cells and show all-in-one adeno-associated virus gene therapy with Cas13bt3 can effectively silence VEGFA mRNA in human retinal organoids and humanized VEGF transgenic mouse models.
[Pharmacy Times] The FDA granted an accelerated approval to asciminib for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
[Nature Immunology] Investigators showed that mice harboring the corresponding Bcl11bN440K mutation show the emergence of natural killer/group 1 innate lymphoid cell-like NKp46+ cells in the thymus and reduction in TBR1+ neurons in the neocortex, which were observed with loss of Bcl11a but not Bcl11b.
[Nature Communications] Scientists reported a self-assembled nano-prodrug composed of aldehyde dehydrogenases activatable photosensitizer and disulfide-linked all-trans retinoic acid for diagnosis and targeted treatment of CSCs enriched tumors.
Investigators combined multicolor lineage tracing with chemical mutagenesis in mice to show that a large proportion of intestinal tumours have a multiancestral origin. Polyclonal tumors retained a structure comprising subclones with...
Crosstalk between vascular endothelial cells and fibroblasts in Idiopathic Pulmonary Fibrosis mediated by bone morphogenic protein signalling may be important for remodeling of the lung. A novel modality for monitoring...
[Nature] Using a recombinant CcCoV receptor-binding domain (RBD) and a human receptor screening platform, scientists identified direct interactions with the human CEACAM proteins CEACAM3, CEACAM5, and CEACAM6.
[Signal Transduction and Targeted Therapy] Investigators revealed the dose-dependent manner and multi-faceted role of the male hormone testosterone in hamster model of COVID-19 by evaluations of manifestations including survival rate, body weight loss, viral load, immune responses, and lung injury.
[Nature] Scientists reported that mRNA–lipid nanoparticle vaccines do not require type 1 conventional dendritic (cDC) cells or the WDFY4-dependent cross-presentation pathway for CD8+ T cell priming but instead engage both cDC1 and cDC2 cells redundantly.